193 related articles for article (PubMed ID: 20381900)
1. Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs.
Vrijens F; Hulstaert F; Van de Sande S; Devriese S; Morales I; Parmentier Y
J Hosp Infect; 2010 Jul; 75(3):158-62. PubMed ID: 20381900
[TBL] [Abstract][Full Text] [Related]
2. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs.
Orsi GB; Di Stefano L; Noah N
Infect Control Hosp Epidemiol; 2002 Apr; 23(4):190-7. PubMed ID: 12002233
[TBL] [Abstract][Full Text] [Related]
3. Cost of intensive care unit-acquired bloodstream infections.
Laupland KB; Lee H; Gregson DB; Manns BJ
J Hosp Infect; 2006 Jun; 63(2):124-32. PubMed ID: 16621137
[TBL] [Abstract][Full Text] [Related]
4. The excess cost associated with healthcare-associated bloodstream infections at Auckland City Hospital.
Burns A; Bowers L; Pak NT; Wignall J; Roberts S
N Z Med J; 2010 Oct; 123(1324):17-24. PubMed ID: 20953218
[TBL] [Abstract][Full Text] [Related]
5. Hospital-acquired infections in Belgian acute-care hospitals: an estimation of their global impact on mortality, length of stay and healthcare costs.
Vrijens F; Hulstaert F; Devriese S; van de Sande S
Epidemiol Infect; 2012 Jan; 140(1):126-36. PubMed ID: 21320376
[TBL] [Abstract][Full Text] [Related]
6. Cost and outcomes of nosocomial bloodstream infections complicating major traumatic injury.
Niven DJ; Fick GH; Kirkpatrick AW; Grant V; Laupland KB
J Hosp Infect; 2010 Dec; 76(4):296-9. PubMed ID: 20705364
[TBL] [Abstract][Full Text] [Related]
7. Economic and clinical impact of nosocomial meticillin-resistant Staphylococcus aureus infections in Singapore: a matched case-control study.
Pada SK; Ding Y; Ling ML; Hsu LY; Earnest A; Lee TE; Yong HC; Jureen R; Fisher D
J Hosp Infect; 2011 May; 78(1):36-40. PubMed ID: 21269733
[TBL] [Abstract][Full Text] [Related]
8. Costs associated with hospital-acquired bacteraemia in a Belgian hospital.
Pirson M; Dramaix M; Struelens M; Riley TV; Leclercq P
J Hosp Infect; 2005 Jan; 59(1):33-40. PubMed ID: 15571851
[TBL] [Abstract][Full Text] [Related]
9. Financial consequences of hospital-acquired bacteraemia in three Belgian hospitals in 2003 and 2004.
Pirson M; Leclercq P; Jackson T; Leclercq M; Garrino M; Sion C
J Hosp Infect; 2008 Jan; 68(1):9-16. PubMed ID: 18055065
[TBL] [Abstract][Full Text] [Related]
10. Costs associated with hospital-acquired bacteraemia in an Indian hospital: a case-control study.
Kothari A; Sagar V; Ahluwalia V; Pillai BS; Madan M
J Hosp Infect; 2009 Feb; 71(2):143-8. PubMed ID: 19058876
[TBL] [Abstract][Full Text] [Related]
11. Length of stay and charges associated with health care-acquired bloodstream infections.
Al-Rawajfah OM; Hewitt JB; Stetzer F; Cheema J
Am J Infect Control; 2012 Apr; 40(3):227-32. PubMed ID: 21621875
[TBL] [Abstract][Full Text] [Related]
12. Bloodstream infections in a German paediatric oncology unit: prolongation of inpatient treatment and additional costs.
Biwersi C; Hepping N; Bode U; Fleischhack G; von Renesse A; Exner M; Engelhart S; Gieselmann B; Simon A
Int J Hyg Environ Health; 2009 Sep; 212(5):541-6. PubMed ID: 19230762
[TBL] [Abstract][Full Text] [Related]
13. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections.
Blot SI; Depuydt P; Annemans L; Benoit D; Hoste E; De Waele JJ; Decruyenaere J; Vogelaers D; Colardyn F; Vandewoude KH
Clin Infect Dis; 2005 Dec; 41(11):1591-8. PubMed ID: 16267731
[TBL] [Abstract][Full Text] [Related]
14. Additional direct medical costs of nosocomial infections: an estimation from a cohort of patients in a French university hospital.
Defez C; Fabbro-Peray P; Cazaban M; Boudemaghe T; Sotto A; Daurès JP
J Hosp Infect; 2008 Feb; 68(2):130-6. PubMed ID: 18201796
[TBL] [Abstract][Full Text] [Related]
15. Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres.
Sheng WH; Wang JT; Lu DC; Chie WC; Chen YC; Chang SC
J Hosp Infect; 2005 Mar; 59(3):205-14. PubMed ID: 15694977
[TBL] [Abstract][Full Text] [Related]
16. Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs.
Primo MG; Guilarde AO; Martelli CM; Batista LJ; Turchi MD
Braz J Infect Dis; 2012; 16(6):503-9. PubMed ID: 23158266
[TBL] [Abstract][Full Text] [Related]
17. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
Warren DK; Quadir WW; Hollenbeak CS; Elward AM; Cox MJ; Fraser VJ
Crit Care Med; 2006 Aug; 34(8):2084-9. PubMed ID: 16763511
[TBL] [Abstract][Full Text] [Related]
18. Burden of meticillin-resistant Staphylococcus aureus infections at a Swiss University hospital: excess length of stay and costs.
Macedo-Viñas M; De Angelis G; Rohner P; Safran E; Stewardson A; Fankhauser C; Schrenzel J; Pittet D; Harbarth S
J Hosp Infect; 2013 Jun; 84(2):132-7. PubMed ID: 23608003
[TBL] [Abstract][Full Text] [Related]
19. Cost of bloodstream infections.
Kilgore M; Brossette S
Am J Infect Control; 2008 Dec; 36(10):S172.e1-3. PubMed ID: 19084149
[TBL] [Abstract][Full Text] [Related]
20. Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database.
Shorr AF; Tabak YP; Killian AD; Gupta V; Liu LZ; Kollef MH
Crit Care Med; 2006 Oct; 34(10):2588-95. PubMed ID: 16915117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
